1. Home
  2. LOB vs NVAX Comparison

LOB vs NVAX Comparison

Compare LOB & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOB
  • NVAX
  • Stock Information
  • Founded
  • LOB 2008
  • NVAX 1987
  • Country
  • LOB United States
  • NVAX United States
  • Employees
  • LOB N/A
  • NVAX N/A
  • Industry
  • LOB Major Banks
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LOB Finance
  • NVAX Health Care
  • Exchange
  • LOB Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • LOB 1.8B
  • NVAX 2.0B
  • IPO Year
  • LOB 2015
  • NVAX 1995
  • Fundamental
  • Price
  • LOB $41.64
  • NVAX $11.63
  • Analyst Decision
  • LOB Buy
  • NVAX Buy
  • Analyst Count
  • LOB 6
  • NVAX 5
  • Target Price
  • LOB $46.83
  • NVAX $15.80
  • AVG Volume (30 Days)
  • LOB 124.9K
  • NVAX 5.1M
  • Earning Date
  • LOB 10-23-2024
  • NVAX 08-08-2024
  • Dividend Yield
  • LOB 0.29%
  • NVAX N/A
  • EPS Growth
  • LOB 74.69
  • NVAX N/A
  • EPS
  • LOB 2.44
  • NVAX N/A
  • Revenue
  • LOB $427,450,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • LOB N/A
  • NVAX N/A
  • Revenue Next Year
  • LOB $16.45
  • NVAX N/A
  • P/E Ratio
  • LOB $17.07
  • NVAX N/A
  • Revenue Growth
  • LOB 14.14
  • NVAX N/A
  • 52 Week Low
  • LOB $26.11
  • NVAX $3.53
  • 52 Week High
  • LOB $47.22
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • LOB 52.26
  • NVAX 44.54
  • Support Level
  • LOB $41.31
  • NVAX $11.26
  • Resistance Level
  • LOB $43.58
  • NVAX $13.84
  • Average True Range (ATR)
  • LOB 1.18
  • NVAX 0.89
  • MACD
  • LOB -0.07
  • NVAX 0.04
  • Stochastic Oscillator
  • LOB 38.61
  • NVAX 22.15

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: